Bioventus

BVS

ATLANTA, GA – – (ACCESSWIRE – January 13, 2023) – – Holzer & Holzer, LLC informs investors that a class action lawsuit has been filed against Bioventus, Inc. (“Bioventus” or the “Company”) (NASDAQ: BVS). The lawsuit alleges Bioventus made materially false and/or misleading statements and/or failed to disclose material adverse facts, including: (1) Bioventus suffered from significant liquidity issues; (2) Bioventus’ rebate practices were unsustainable; (3) accordingly, Bioventus overstated its business and financial prospects; (4) Bioventus maintained deficient disclosure controls and procedures and internal control over financial reporting with respect to the timely recognition of quarterly rebates; and (5) all the foregoing increased the risk that the Company would be forced to recognize a significant non-cash impairment charge, could not timely file one or more of its financial reports, would have to amend one or more of its financial statements, and could not meet its financial obligations as they came due.

If you bought shares of Bioventus between February 11, 2021 and November 21, 2022 or in connection with Bioventus’ initial public offer and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at cholzer@holzerlaw.com or Marshall P. Dees, Esq. at mdeees@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at https://holzerlaw.com/case/bioventus/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is March 13, 2023.

 

Registration Deadline

Lead Plaintiff Deadline Has Passed

March 13, 2023

Submit Your Information

Name(Required)
Address
MM slash DD slash YYYY
Shares Purchased(Required)
Number of Shares Acquired
Acquisition Price Per Share
 
MM slash DD slash YYYY
Shares Sold
Number of Shares Sold
Selling Price Per Share
 
By clicking on the button below, I am requesting Holzer & Holzer, LLC send me documents necessary to retain the firm.